Thesis
PanicFade v4 rests on a specific, falsifiable claim: negative headline shocks are overreacted to and tend to revert toward fundamentals. It buys large caps hit by sentiment below −0.4 that are simultaneously oversold on price — RSI14 under 35 and trading below their 20-day moving average — and it sizes into the panic rather than waiting for confirmation. Exits are rules-based: RSI14 back above 50 or price reclaiming the SMA20, with a hard stop on fresh lows under continued negativity, treated as evidence of a fundamental break rather than noise. The design cites recent sentiment-feedback research (arXiv:2509.11970 and a 2025 JRFM study), which counts in its favour — the edge is motivated, not curve-fit after the fact.
Recent activity
Activity has been quiet. Across the scheduled runs from 2 to 9 October, five of six placed no trades; only the 7 October run executed, with two orders. That restraint is by design — the strategy waits for a rare sentiment-plus-oversold coincidence — but it leaves the book mostly in cash ($5,238.84 of a $9,840.72 total). The trade log shows the pattern at work: a BAC position sold on 1 October at $53.60 and re-entered on 7 October at $53.40, a deep-panic NKE buy at $36.10, and smaller positions in HD, MCD and UNH. Positions are opportunistic, and rotation is frequent.
Backtest and validation
Over 1,233 days the backtest returned 37.93% (6.79% CAGR) with a Sharpe of 0.96, a 9.3% max drawdown, and a 62.88% win rate across 530 trades. The validation is the stronger story: four walk-forward folds, all positive (1.6%, 3.88%, 10.14%, 21.7%), a probabilistic Sharpe ratio of 0.985, and an out-of-sample Sharpe of 2.44 in the most recent fold. The deflated Sharpe ratio — which penalises for the 27 trials run during development — lands at 0.56, far more sobering than the headline PSR.
Strengths and risks
The strengths are genuine: consistently positive folds, a motivated thesis, shallow drawdowns, and disciplined rules-based exits. The risks deserve equal billing. The headline Sharpe is under 1 and the CAGR is modest. Most of the cumulative return concentrates in the final fold (21.7%), while the 2021–22 bear fold barely cleared zero (1.6%, Sharpe 0.19) — a warning that the fade can stall when negativity is justified. Turnover of 5,807% is extreme, and $530 of fees across 530 trades is a visible drag on a small book.
Verdict
PanicFade v4 is a well-constructed, literature-grounded strategy whose recent out-of-sample run looks excellent. But its multiple-testing-adjusted edge is thinner than the top-line numbers suggest, and the DSR of 0.56 — close to a coin flip — is the honest number to keep watching as the live book builds a track record.